Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Allegro Ophthalmics

Allegro Ophthalmics
2011 FOUNDED
PRIVATE STATUS
Conv. Debt LATEST DEAL TYPE
$10.3M LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of ophthalmic drugs designed for the treatment of wet age-related macular degeneration. The company provides treatment for neovascular eye diseases including age-related macular degeneration, diabetic retinopathy and diabetic macular edema, enabling patients to stay healthier for longer.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
  • 31473 Rancho Viejo Road
  • Suite 204
  • San Juan Capistrano, CA 92675
  • United States

+1 (949) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Allegro Ophthalmics’s full profile, request a free trial.

Allegro Ophthalmics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Convertible Debt 15-Jan-2019 $10.3M 000.00 Completed Clinical Trials - Phase 1
4. Early Stage VC 09-Jul-2017 000.00 000.00 Completed Clinical Trials - Phase 1
3. Grant 03-Feb-2015 000 000.00 Completed Clinical Trials - Phase 1
2. Early Stage VC 26-Jan-2015 $20.3M $21.8M Completed Clinical Trials - Phase 1
1. Angel (individual) 01-Apr-2012 $1.5M $1.5M Completed Clinical Trials - Phase 1
To view this company’s complete deal history including valuation and funding, request access »

Allegro Ophthalmics Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MacuClear Formerly VC-backed Richardson, TX 0 000 0000000000 0 000
0000000 Venture Capital-Backed Cambridge, United Kingdom 00 00.000 0000000000 0 00.000
000000000 Venture Capital-Backed Cumberland, RI 00 000.00 00000000000 000.00
000 000000000000 Venture Capital-Backed Ann Arbor, MI 0 0000 000000 0
000000 00000000 Formerly VC-backed Palo Alto, CA 00 00000 00000000 00000
To view this company’s complete list of competitors, request access »

Allegro Ophthalmics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
The Leona M. and Harry B. Helmsley Charitable Trust Lender/Debt Provider 000 0000 000000 0
Hanmi Pharmaceuticals Corporation Minority 000 0000 000000 0

Allegro Ophthalmics Executive Team (6)

Name Title Board
Seat
Contact
Info
Vicken Karageozian MD Co-Founder & Chief Executive Officer
Scott Cooper Chief Financial Officer and Vice President of Business Development
Lisa O'Dwyer Director of Clinical Research & Board Member
John Park Ph.D Co-Founder, Chief Scientific Officer, Vice President of Product Development and Board Member
Hampar Karageozian Ph.D Co-Founder & Executive Chairman

1 Former Executive

You’re viewing 5 of 6 executives. Get the full list »

Allegro Ophthalmics Board Members (12)

Name Representing Role Since Contact
Info
Hampar Karageozian Ph.D Allegro Ophthalmics Co-Founder & Executive Chairman 000 0000
John Park Allegro Ophthalmics Board Member 000 0000
Lisa Karageozian Allegro Ophthalmics Board Member 000 0000
Lisa O'Dwyer Allegro Ophthalmics Director of Clinical Research & Board Member 000 0000
Marc Carlson Allegro Ophthalmics Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 12 board members. Get the full list »